Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study

BMC Pulmonary Medicine

Volumn 11, Issue , 2011, Pages

  Barnestein Fonseca, Pilar ^a   Leiva Fernández, José ^b   Vidal España, Francisca ^c   García Ruiz, Antonio ^d   Prados Torres, Daniel ^a   Leiva Fernández, Francisca ^a  

^a Family and Community Medicine Teaching Unit of Malaga   (Spain)

^b Velez Sur Health Centre   (Spain)

^c Health District Malaga   (Spain)

^d UNIVERSIDAD DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID;

AGED; ARTICLE; ATTITUDE TO HEALTH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COHORT ANALYSIS; DEMOGRAPHY; DISEASE EXACERBATION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SENSITIVITY AND SPECIFICITY; SMOKING; SOCIAL STATUS; SPAIN; SPIROMETRY; PREDICTIVE VALUE;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; CHOLINERGIC ANTAGONISTS; COHORT STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SELF REPORT;

EID: 78751644212     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-11-6     Document Type: Article

References (38)

1. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease?. Chest 2003, 123:1684-92. 10.1378/chest.123.5.1684, 12740290.
2. Murray C, López A. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-504. 10.1016/S0140-6736(96)07492-2, 9167458.
3. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008, 63:831-38. 10.1136/thx.2007.086041, 18728206.
4. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004, 42:200-9. 10.1097/01.mlr.0000114908.90348.f9, 15076819.
5. World Health Organization Adherence to long-term therapies: evidence for action. Meeting report 4-5 June 2001. Available at: (accessed May 2009), World Health Organization., http://www.who.int/chp/knowledge/publications/adherence_introduction.pdf
6. Anthonisen NR, Connet JE, Kiley MD, Bailey WC, Buist SA. Effects of smoking intervention and the use of inhaled anticholinergic bronchodilator on the rate of decline of FEV1: The Lung Health Study. JAMA 1994, 272:1497-1505. 10.1001/jama.272.19.1497, 7966841.
7. Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, Sikkema-Ortiz J, Gardner DD, Wilkins RL. Medication adherence in patients treated for COPD. Int J COPD 2008, 3:371-384.
8. George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 2005, 128:3198-3204. 10.1378/chest.128.5.3198, 16304262.
9. Rapoff MA, Barlet SJ. Adherence in children and adults. 2006, 279-84. Clinical care in the rheumatic diseases. Atlanta: American College of Rheumatology, Barlett SJ.
10. Farmer KC. Methods for measuring and monitoring medication adherence in clinical trials and clinical practice. Clin Ther 1999, 21:1074-90. 10.1016/S0149-2918(99)80026-5, 10440628.
11. Bender B, Milgrom H, Apter A. Adherence intervention research: what have we learned and what do we do next?. J Allergy Clin Immunol 2003, 112:489-94. 10.1016/S0091-6749(03)01718-4, 13679805.
12. Rand CS. I took the medicine like you told me, doctor: self-report of adherence with medical regimes. The Science of self-report: implications for research and practice 2000, 257-76. Mahway, NJ: Lawrence Erlbaum Associate, Stone A.
13. Simmons MS, Nides MA, Rand CS, Wise RA, Tashkin DP. Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest 2000, 118:290-5. 10.1378/chest.118.2.290, 10936115.
14. Sanchís-Aldás J, Casan-Clará P, Castillo-Gómez J, Gómez-Mangado N, Palenciano-Ballesteros L, Roca-Torrent J. Normativa SEPAR Espirometría forzada. Available at: (accessed may 2010)., http://www.separ.es/publicaciones/normativas_y_procedimientos.html
15. Jones PW, Quirk FH, Bayeysstock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
16. Ferrer M, Alonso J, Prieto L, Plaza V, Monso E, Marrades R, Aguar MC, Khalaf A, Anto JM. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Euro Respir J 1996, 9:1160-66.
17. Lehane E, Mc-Carthy G. Medication non-adherence: exploring the conceptual mire. Inter J Nurs Pract 2009, 15:25-31.
18. Simmons MS, Nides MA, Kleerup EC, Chapman KR, Milgrom H, Rand CS, Spector SL, Tashkin DP. Validation of the DOSER, a new device for monitoring metered-dose inhaler use. J Allergy Clin Immunol 1998, 102:409-413. 10.1016/S0091-6749(98)70128-9, 9768581.
19. Sackett DL, Haynes RB, Gibson ES. Ramdomized clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1975, 1:1205-1207. 10.1016/S0140-6736(75)92192-3, 48832.
20. Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 2009, 43:413-22. 10.1345/aph.1L496, 19261962.
21. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance?. Hypertension 1980, 2:757-764.
22. Morinsky DE, Green LW, Levine AM. Concurrent and predictor validity of a self reported measure of medication adherence. Med Care 1986, 1:67-74.
23. Batalla A, Blanquer R, Ciurana M, García M, Jordi E, Pérez A. Cumplimiento de la prescripción farmacológica en pacientes hipertensos. Aten Primaria 1984, 1:185-91.
24. Piñeiro F, Gil V, Donis M, Orozco D, Pastor A, Merino J. Validez de 6 métodos indirectos para valorar el cumplimiento del tratamiento farmacológico en la hipertensión arterial. Aten Primaria 1997, 19(7):372-6.
25. Piñeiro F, Gil V, Donis M, Orozco D, Pastor A, Merino J. Validez de 6 métodos indirectos para valorar el cumplimiento del tratamiento farmacológico en las dislipemias. Aten Primaria 1997, 19(9):465-8.
26. Cabello JB, Pozo F. Métodos de investigación en cardiología clínica(X). Estudios de evaluación de las pruebas diagnósticas en cardiología. Rev Esp Cardiol 1997, 50:507-19.
27. Riegelman RK, Hirsch RP. Studying a study and testing a test. 1996, Brown and Company; Boston, Little, 3.
28. Sobradillo V, Mirtavilles M, Jimenez CA, Gabriel R, Viejo JL, Masa JF, Viejo JL, Fernández-Fau L. Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo. Arch Bronconeumol 1999, 35:159-166.
29. Sobradillo V, Miratvilles M, Gabriel R, Jiménez CA, Villasante C, Masa JF, Viejo JL, Fernández-Fau L. Geographic Variations in Prevalence and Underdiagnosis of COPD: Results of the IBERPOC Multicentre Epidemiological Study. Chest 2000, 118:981-89. 10.1378/chest.118.4.981, 11035667.
30. Barberá JA, Peces-Barba G, Agustí AGN, Izquierdo JL, Monsó E, Montemayor T, Viejo JL. Guía clínica para el diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 2001, 37:297-316.
31. Global PR. Initiative for Chronic Obstructive Lung Disease (GOLD): A collaborative Project of the National Health, Lung, and Blood Institute, NIH and World Health Organisation. 2005, Available at: (accessed May 2009)., http://goldcopd.com
32. García Pérez AM, Leiva Fernández F, Martos Crespo F, García Ruiz AJ, Prados Torres D, Sánchez de la Cuesta y Alarcón F. ¿Cómo diagnosticar el cumplimiento terapéutico en Atención Primaria. Medicina de Familia (And) 2000, 1:13-9.
33. van Onzenoort HAW, Verberk WJ, Kessels A, Kroon A, Neef C, van der Kuy PH, Leeuw PW. Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild to moderate hypertension. Am J Hypert 2010, 23:149-154.
34. Piñeiro F, Gil VF, Donis M, Orozco D, Pastor R, Merino J. Validez de seis métodos indirectos para valorar el cumplimiento del tratamiento farmacológico en la diabetes no insulindependiente. Rev Clin Esp 1997, 197:555-9.
35. Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2007, 146(8):545-55.
36. Bender BG, Pedan A, Varasteh LT. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 2006, 118(4):899-904. 10.1016/j.jaci.2006.07.002, 17030244.
37. Crompton GK, Barnes PJ, Broeders M, Corrigan C, Corbetta L, Dekhuijzen R, Dubus JC, Magnan A, Massone F, Sanchis J, Viejo JL, Voshaar T. The need to improve inhalation technique in Europe a report from the Aerosol Drug Management Improvement Team. Respir Med 2006, 100(9):1479-94. 10.1016/j.rmed.2006.01.008, 16495040.
38. Altman DG. Practical Statistic for medical research. 1996, London: Edit Chapman and Hall, 2.